Back

SWEDEHEART - Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

3 September 2019 (11:18 - 11:30)
Organised by:
Congress Presentation Part of: Hot Line Session 5 Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Erik Bjoerklund

Sahlgrenska Academy, Gothenburg (Sweden)

12 More presentations in this session

Presentation thumbnail
CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommended therapies. Final 5-year results from the CLARIFY study
Doctor E. Sorbets (Paris, FR)
Slides Video
Presentation thumbnail
Discussant review - CLARIFY
Professor D. Hasdai (Petah Tikva, IL)
Slides Video
Presentation thumbnail
Questions from the audience and discussion
Video
Presentation thumbnail
Discussant review - SWEDEHEART
Professor V. Falk (Berlin, DE)
Slides Video
Presentation thumbnail
Questions from the audience and discussion
Video

Access the full session

Session thumbnail
Hot Line Session 5

The Event

Event poster

ESC Congress 2019

3 September 2019 11:18 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources